These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 33799414)
1. Phage Therapy for Mycobacterium Abscessus and Strategies to Improve Outcomes. Hashemi Shahraki A; Mirsaeidi M Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33799414 [TBL] [Abstract][Full Text] [Related]
2. Mycobacterium abscessus Strain Morphotype Determines Phage Susceptibility, the Repertoire of Therapeutically Useful Phages, and Phage Resistance. Dedrick RM; Smith BE; Garlena RA; Russell DA; Aull HG; Mahalingam V; Divens AM; Guerrero-Bustamante CA; Zack KM; Abad L; Gauthier CH; Jacobs-Sera D; Hatfull GF mBio; 2021 Mar; 12(2):. PubMed ID: 33785625 [No Abstract] [Full Text] [Related]
3. Considerations for Phage Therapy Against Senhaji-Kacha A; Esteban J; Garcia-Quintanilla M Front Microbiol; 2020; 11():609017. PubMed ID: 33537013 [TBL] [Abstract][Full Text] [Related]
4. Toward a Phage Cocktail for Tuberculosis: Susceptibility and Tuberculocidal Action of Mycobacteriophages against Diverse Mycobacterium tuberculosis Strains. Guerrero-Bustamante CA; Dedrick RM; Garlena RA; Russell DA; Hatfull GF mBio; 2021 May; 12(3):. PubMed ID: 34016711 [TBL] [Abstract][Full Text] [Related]
5. Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection. Nick JA; Dedrick RM; Gray AL; Vladar EK; Smith BE; Freeman KG; Malcolm KC; Epperson LE; Hasan NA; Hendrix J; Callahan K; Walton K; Vestal B; Wheeler E; Rysavy NM; Poch K; Caceres S; Lovell VK; Hisert KB; de Moura VC; Chatterjee D; De P; Weakly N; Martiniano SL; Lynch DA; Daley CL; Strong M; Jia F; Hatfull GF; Davidson RM Cell; 2022 May; 185(11):1860-1874.e12. PubMed ID: 35568033 [TBL] [Abstract][Full Text] [Related]
6. Alternative and Experimental Therapies of Meir M; Barkan D Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32948001 [No Abstract] [Full Text] [Related]
7. Fluorescent Reporter DS6A Mycobacteriophages Reveal Unique Variations in Infectibility and Phage Production in Mycobacteria. Mayer O; Jain P; Weisbrod TR; Biro D; Ho L; Jacobs-Sera D; Hatfull GF; Jacobs WR J Bacteriol; 2016 Dec; 198(23):3220-3232. PubMed ID: 27672191 [TBL] [Abstract][Full Text] [Related]
8. Mycobacteriophage-antibiotic therapy promotes enhanced clearance of drug-resistant Mycobacterium abscessus. Johansen MD; Alcaraz M; Dedrick RM; Roquet-Banères F; Hamela C; Hatfull GF; Kremer L Dis Model Mech; 2021 Sep; 14(9):. PubMed ID: 34530447 [TBL] [Abstract][Full Text] [Related]
9. Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease. Dedrick RM; Smith BE; Cristinziano M; Freeman KG; Jacobs-Sera D; Belessis Y; Whitney Brown A; Cohen KA; Davidson RM; van Duin D; Gainey A; Garcia CB; Robert George CR; Haidar G; Ip W; Iredell J; Khatami A; Little JS; Malmivaara K; McMullan BJ; Michalik DE; Moscatelli A; Nick JA; Tupayachi Ortiz MG; Polenakovik HM; Robinson PD; Skurnik M; Solomon DA; Soothill J; Spencer H; Wark P; Worth A; Schooley RT; Benson CA; Hatfull GF Clin Infect Dis; 2023 Jan; 76(1):103-112. PubMed ID: 35676823 [TBL] [Abstract][Full Text] [Related]
10. Mycobacteriophage-drived diversification of Mycobacterium abscessus. Sassi M; Gouret P; Chabrol O; Pontarotti P; Drancourt M Biol Direct; 2014 Sep; 9():19. PubMed ID: 25224692 [TBL] [Abstract][Full Text] [Related]
11. Unusual prophages in Mycobacterium abscessus genomes and strain variations in phage susceptibilities. Amarh ED; Dedrick RM; Garlena RA; Russell DA; Gauthier CH; Aull HG; Abad L; Jacobs-Sera D; Akusobi C; Rubin EJ; Hatfull GF PLoS One; 2023; 18(2):e0281769. PubMed ID: 36795728 [TBL] [Abstract][Full Text] [Related]
12. Understanding the Phage-Host Interaction Mechanism toward Improving the Efficacy of Current Antibiotics in Gorzynski M; De Ville K; Week T; Jaramillo T; Danelishvili L Biomedicines; 2023 May; 11(5):. PubMed ID: 37239050 [TBL] [Abstract][Full Text] [Related]
13. Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future. Łobocka M; Dąbrowska K; Górski A BioDrugs; 2021 May; 35(3):255-280. PubMed ID: 33881767 [TBL] [Abstract][Full Text] [Related]
14. Association between sequevar and antibiotic treatment outcome in patients with Mycobacterium abscessus complex infections in Japan. Yoshida S; Tsuyuguchi K; Kobayashi T; Tomita M; Inoue Y; Hayashi S; Suzuki K J Med Microbiol; 2018 Jan; 67(1):74-82. PubMed ID: 29227218 [TBL] [Abstract][Full Text] [Related]